Infarct Size, Microvascular Obstruction and Outcomes in STEMI: An Expert Panel Discussion
Despite advances in reperfusion with primary stenting, STEMI outcomes have stagnated over the past 20 years.
Moderated by Dr Nadia Sutton (Michigan, US), this broadcast will bring together global thought leaders, Dr Babar Basir (Michigan, US), Dr Dan Burkhoff (New York, US), Dr Suzanne de Waha (Luebeck, DE) and Dr Jay Traverse (Minnesota, US), to discuss the rationale and science behind STEMI outcomes, what needs to be done to improve them and what emerging technologies can help.
Participants of this broadcast will find out which patients are at greatest risk of microvascular obstruction (MVO) and large infarcts, how we can diagnose MVO and how we can treat MVO and infarct.
This broadcast is third in a series of four focusing on Supersaturated Oxygen (SSO2) Therapy.
Suzanne de Waha
This broadcast is supported by:
Overview of the Problem: Microvascular Obstruction and Infarct Size in STEMI
Dr Suzanne de Waha
Which patients are at greatest risk of MVO and large infarcts?
How does this change our roles as interventional cardiologists?
How can we diagnose MVO?
How can we treat MVO and infarct?
Develop an understanding of:
- The impact of infarct size and microvascular obstruction on STEMI outcomes
- Supporting science
- New treatment modalities to help improve outcomes
- Interventional Cardiologists
- Heart Failure Specialists
Suzanne de Waha
Dr Suzanne de Waha works at University Heart Center, Luebeck, DE.
Her main focus is acute myocardial infarction (STEMI + NSTEMI), cardiac imaging including CMR, cardiogenic shock, assist devices, interventional cardiology and structural heart disease including TAVI.
Dr de Waha has >150 publications in peer-reviewed, international high-ranked journals.
Dr Jay Traverse is a senior consulting cardiologist at Minneapolis Heart Institute, Minnesota, US. He is also the Director of Research at MHIF and an Associate Professor of Medicine at the University of Minnesota School of Medicine, Minnesota, US.
His special interests include interventional cardiology, stem cell therapy, biomaterials, and ischemia/reperfusion injury.
Dr Babar Basir is an Interventional Cardiologist at the Henry Ford Hospital in Detroit, Michigan, US.
Dr Basir specialises in the treatment of complex heart blockage with minimally invasive techniques using balloons and stents. He is a national leader in the treatment of cardiogenic shock and lectures around the world on the use of temporary heart pumps when the heart is failing.
Dr Dan Burkhoff is currently the Director of Heart Failure, Hemodynamics and MCS Research at Cardiovascular Research Foundation, New York, US. Dr Burkhoff's interest include cardiovascular modelling and ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices. He is also author of Harvi, an interactive simulation-based application for teaching and researching on ventricular mechanics and hemodynamics.
Dr Nadia Sutton is an Assistant Professor, interventional cardiologist and vascular biologist in the Division of Cardiovascular Medicine and the Frankel Cardiovascular Center at University of Michigan, Michigan, US.